Life ScienceCompany
CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets Ownership
Who owns CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets?
CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets is owned by Baxter International. It was acquired on July 29, 2021.
CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets Business Overview
Where is CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets headquartered?
CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets is headquartered in Kennesaw, Georgia.
What sector is CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets in?
CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets is a life science company.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.